Clara Houdayer,A Marie Phillips,Marie Chabbert,Jennifer Bourreau,Reza Maroofian,Henry Houlden,Kay Richards,Nebal Waill Saadi,Eliška Dad’ová,Patrick Van Bogaert,Mailys Rupin,Boris Keren,Perrine Charles,Thomas Smol,Audrey Riquet,Lynn Pais,Anne O’Donnell-Luria,Grace E. VanNoy,Allan Bayat,Rikke S Møller,Kern Olofsson,Rami Abou Jamra,Steffen Syrbe,Majed Dasouki,Laurie H Seaver,Jennifer A Sullivan,Vandana Shashi,Fowzan S Alkuraya,Alexis F Poss,J Edward Spence,Rhonda E Schnur,Ian C Forster,Chaseley E Mckenzie,Cas Simons,Min Wang,Penny Snell,Kavitha Kothur,Michael Buckley,Tony Roscioli,Noha Elserafy,Benjamin Dauriat,Vincent Procaccio,Daniel Henrion,Guy Lenaers,Estelle Colin,Nienke E. Verbeek,Koen L. Van Gassen,Claire Legendre,Dominique Bonneau,Christopher A Reid,Katherine B Howell,Alban Ziegler,Christian Legros

Abstract:Hyperpolarization activated Cyclic Nucleotide (HCN) gated channels are crucial for various neurophysiological functions, including learning and sensory functions, and their dysfunction are responsible for brain disorders, such as epilepsy. To date, variants have only been associated with mild epilepsy and recently, one monoallelic missense variant has been linked to developmental and epileptic encephalopathy. Here, we expand the phenotypic spectrum of related disorders by describing twenty-one additional individuals from fifteen unrelated families carrying variants. Seventeen individuals had developmental delay/intellectual disability (DD/ID), two had borderline DD/ID, and one had borderline DD. Ten individuals had epilepsy with DD/ID, with median age of onset of 10 months, and one had epilepsy with normal development. Molecular diagnosis identified thirteen different pathogenic variants, including eleven missense variants affecting highly conserved amino acids, one frameshift variant, and one in-frame deletion. Seven variants were monoallelic of which five occurred one was not maternally inherited, one was inherited from a father with mild learning disabilities, and one was of unknown inheritance. The remaining six variants were biallelic, with four homozygous and two compound heterozygous variants. Functional studies using two-electrode voltage-clamp recordings in oocytes were performed on three monoallelic variants, p.(Arg324His), p.(Ala363Val), and p.(Met374Leu), and three biallelic variants, p.(Leu377His), p.(Pro493Leu) and p.(Gly587Asp). The p.(Arg324His) variant induced a strong increase of HCN2 conductance, while p.(Ala363Val) and p.(Met374Leu) displayed dominant negative effects, leading to a partial loss of HCN2 channel function. By confocal imaging, we found that the p.(Leu377His), p.(Pro493Leu) and p.(Gly587Asp) pathogenic variants impaired membrane trafficking, resulting in a complete loss of HCN2 elicited currents in oocytes. Structural 3D-analysis in depolarized and hyperpolarized states of HCN2 channels, revealed that the pathogenic variants p.(His205Gln), p.(Ser409Leu), p.(Arg324Cys), p.(Asn369Ser) and p.(Gly460Asp) modify molecular interactions altering HCN2 function. Taken together, our data broadens the clinical spectrum associated with variants, and disclose that is involved in developmental encephalopathy with or without epilepsy.

A recurrent, homozygous EMC10 frameshift variant is associated with a syndrome of developmental delay with variable seizures and dysmorphic features

Bi-allelic loss-of-function variants in TMEM147 cause moderate to profound intellectual disability with facial dysmorphism and pseudo-Pelger-Huët anomaly

Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism

Novel SNX13 Frameshift Variant in an Individual with Developmental Delay.

Stretch-activated ion channel TMEM63B associates with developmental and epileptic encephalopathies and progressive neurodegeneration

A recurrent missense variant in the E3 ubiquitin ligase substrate recognition subunit FEM1B causes a rare syndromic neurodevelopmental disorder

Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures

Pathogenic variants in cause a neurodevelopmental syndrome via alteration of metabolic signaling

Pathogenic variants in TMEM184B cause a neurodevelopmental syndrome via alteration of metabolic signaling

A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.

A Novel Frameshift CHD4 Variant Leading to Sifrim-Hitz-Weiss Syndrome in a Proband with a Subclinical Familial t(17;19) and a Large dup(2)(q14.3q21.1)

Identification of an Identical De Novo SCAMP5 Missense Variant in Four Unrelated Patients with Seizures and Severe Neurodevelopmental Delay.

SMC1A epilepsy syndrome: clinical data from a large international cohort

Mono and biallelic variants in cause severe neurodevelopmental disorders

Heterozygous variants disrupting the interaction of ERF with activated ERK1/2 cause microcephaly, developmental delay, and skeletal anomalies

De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues

A novel de novo frameshift variant in the CHD2 gene related to intellectual and developmental disability, seizures and speech problems

Novel compound heterozygous variants in EMC1: Overlapping phenotypes of left ventricular noncompaction and long QT syndrome warranting in‐depth exploration

Epigenomic and phenotypic characterization of DEGCAGS syndrome

De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy